查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1857277

全球體外膜氧氣療法（ECMO）設備市場

Extracorporeal Membrane Oxygenation (ECMO) Machine
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 294 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球體外膜氧氣療法（ECMO）設備市場預計2030年將達到8.747億美元

全球體外膜氧氣療法（ECMO）設備市場規模在2024年估計為6.438億美元，預計2024年至2030年將以5.2%的複合年成長率成長，到2030年達到8.747億美元。本報告分析的細分市場之一－新生兒患者市場，預計複合年成長率也將達到5.2%，到分析期結束時達到5.007億美元。兒科患者市場預計在分析期內將以5.7%的複合年成長率成長。

美國市場規模估計為1.675億美元，中國市場預計將以8.0%的複合年成長率成長。

預計2024年，美國體外膜氧氣療法（ECMO）設備市場規模將達1.675億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到1.974億美元，在2024年至2030年的分析期內，複合年成長率（CAGR）將達到8.0%。其他值得關注的區域市場包括日本和加拿大，預計在分析期內，這兩個市場的複合年成長率將分別達到3.1%和4.1%。在歐洲，德國的複合年成長率預計將達到3.8%。

全球體外膜氧氣療法（ECMO）設備市場－主要趨勢與促進因素概述

體外膜氧氣療法（ECMO）設備如何革新重症加護？

體外膜氧氣療法（ECMO）機正在改變重症加護，為患有嚴重呼吸衰竭和心臟衰竭的患者提供挽救生命的支持。 ECMO 是一種體外生命支持（ECLS）技術，它在體外為患者的血液進行氧合，使心臟和肺部得以休息和恢復。 ECMO 機的工作原理是從病人體內抽取血液，去除二氧化碳，添加氧氣，然後將氧合後的血液輸回病人體內。這個過程為患有急性呼吸窘迫症候群（ARDS）、心源性休克、心血管手術併發症以及等待肺移植或心臟移植的患者提供了至關重要的生命線。

體外膜氧合（ECMO）技術的出現徹底改變了危及生命的呼吸系統和心臟疾病患者的治療方式，尤其是在機械通氣等傳統治療方法無效的情況下。 ECMO設備目前已廣泛應用於新生兒、兒科和成人加護病房（ICU），作為其他治療方法無效時的最後手段。 ECMO系統能夠長時間維持氧合和血液循環，為心臟和肺部的修復爭取了寶貴的時間，從而提高了嚴重患者的生存率。隨著ECMO技術的不斷進步，其在重症加護中的應用日益廣泛，為那些原本預後不良的患者帶來了希望。

為什麼體外膜氧合（ECMO）裝置對於治療嚴重的呼吸衰竭和心臟衰竭至關重要？

體外膜氧合（ECMO）機對於治療重度呼吸衰竭和心臟衰竭患者至關重要，因為它能為重要器官提供暫時的支持，即使其他醫療手段無效，也能幫助患者恢復。在急性呼吸窘迫症候群（ARDS）或肺炎等重度呼吸衰竭病例中，肺部無法充分氧合血液，這可能導致危及生命的併發症。 ECMO完全繞過肺部，在體外對血液進行氧合，然後再送回循環系統，確保重要器官獲得氧氣，同時肺部得以休息和恢復。這對於因創傷、感染疾病或長期機械通氣而導致肺部受損的患者尤其重要，因為這些患者無法透過常規機械通氣維持氧合水平。

同樣，體外膜氧合（ECMO）對於心臟衰竭患者，包括心血管手術、心臟病發作和心源性休克後的復健患者，都是一項重要的治療手段。在這些情況下，ECMO透過維持血液循環和氧氣供應來取代心臟功能。這使得心臟能夠從壓力和損傷中恢復，並預防因血流不足導致的器官衰竭等併發症。 ECMO也可以作為通往更永久性治療方案（例如心臟或肺移植）的橋樑，為重症患者爭取時間，直到有合適的器官可供移植。 ECMO在緊急情況下（例如用於治療嚴重COVID-19併發症患者）的日益普及，證明了ECMO在其他治療無效時是提供生命維持的寶貴工具，凸顯了其在現代重症患者監護中的重要性。

ECMO技術有哪些不斷擴展的應用與創新？

ECMO技術的應用範圍正在迅速擴展，該領域的創新使其應用超越了傳統範疇，並增強了其在治療重症患者方面的能力。 ECMO最初主要用於新生兒和兒科重症監護室，如今已成為治療成人嚴重呼吸或心臟衰竭患者的常用手段。在新冠肺炎疫情期間，ECMO在治療成人呼吸系統疾病中的作用尤其引人注目，當時ECMO被用於支持因新冠病毒感染而出現嚴重呼吸併發症的患者。隨著我們對這項技術的理解不斷加深，ECMO的應用範圍不斷擴大，包括嚴重肺損傷的創傷患者、需要復甦的心臟麻痹患者以及大型手術併發症患者。

ECMO技術的創新正在提升其安全性、效率和可近性。近期進展包括可攜式ECMO機的研發，使得重症患者能夠在醫院之間以及大型醫療機構內部進行轉運。這些可攜式系統使患者在轉運至專科護理中心的過程中能夠接受挽救生命的治療，從而提高需要複雜護理患者的生存率。此外，迴路設計和材料的改進，例如可降低血栓和發炎風險的生物相容性塗層，也使ECMO治療在長期應用中更安全有效。氧合器和氧合泵（ECMO功能的核心部件）的進步也提高了氧氣交換效率，進一步改善了患者的預後。

此外，將人工智慧 (AI) 和數據分析技術整合到體外膜氧合 (ECMO) 系統中，為個人化護理開闢了新的可能性。 AI 演算法可以即時監控和調整 ECMO 參數，根據每位患者的個別情況最佳化治療方案。這種精準性可以降低 ECMO 相關風險，例如出血和血栓形成，並改善重症患者的整體管理。隨著體外生命支持領域的研究和技術不斷進步，ECMO 的應用範圍正在從重症監護室 (ICU) 擴展到其他領域，有望成為急診護理、創傷治療，甚至心肺疾病患者長期慢性病護理的重要組成部分。

哪些因素推動了體外膜氧合（ECMO）市場的成長？

體外膜氧氣療法（ECMO）設備市場的成長受多種關鍵因素驅動，包括呼吸系統和心臟疾病盛行率的上升、ECMO技術的進步以及ECMO在重症加護環境中的日益普及。其中一個關鍵促進因素是急性呼吸窘迫症候群（ARDS）、心源性休克和心臟衰竭等疾病的盛行率不斷上升，這些疾病死亡率高，且通常需要高階生命維持。新冠肺炎疫情也使ECMO成為關注焦點，因為全球醫療系統都面臨大量嚴重呼吸衰竭患者，當其他治療方法（例如機械通氣）無效時，這些患者需要ECMO支援。 ECMO在提高急性肺衰竭患者生存率方面的成功，使其在呼吸危機管理中的價值得到廣泛認可，從而導致重症監護室和急診科對ECMO設備的需求增加。

技術進步在體外膜氧合（ECMO）市場成長中也發揮關鍵作用。設備設計的創新，例如更緊湊便攜的ECMO設備的研發，使得在接受ECMO支援治療期間轉運患者更加便捷。這使得ECMO的應用範圍超越了傳統的醫院環境，使其能夠應用於野戰醫院、救護車和其他緊急醫療場景。此外，呼吸器效率、幫浦技術和生物相容性材料的改進降低了ECMO治療相關的風險，例如血栓和感染。這些技術創新正在改善患者的治療效果，並推動ECMO在全球醫院的普及應用。

推動體外膜氧合（ECMO）市場成長的另一個主要因素是人們對ECMO在治療重症患者方面的益處認知不斷提高，尤其是在ECMO技術先前未充分利用的地區。醫護人員接受的ECMO設備操作和管理方面的培訓和教育不斷加強，促使這項技術廣泛應用。此外，隨著發展中地區醫療體系的改善，對ECMO等先進生命維持技術的需求日益成長，這些技術被認為是治療複雜呼吸衰竭和心臟衰竭病例的關鍵。同時，優惠的報銷政策和政府對重症患者監護基礎設施的支持也促進了市場擴張，使全球各地的醫院和診所更容易獲得ECMO服務。

總之，在嚴重呼吸系統和心臟疾病發病率不斷上升、ECMO技術不斷進步以及人們對ECMO救命能力的認知日益提高的推動下，ECMO設備市場有望實現顯著成長。隨著ECMO技術的不斷發展，其應用範圍將擴展到重症監護、緊急應變甚至長期照護領域，為改善嚴重器官衰竭患者的預後提供新的可能性。隨著技術的持續創新和醫療基礎設施投資的不斷增加，ECMO設備有望繼續成為現代重症監護的重要組成部分，為重症患者帶來希望和救命支持。

部分

輸注方式（靜脈-動脈 (VA)、靜脈-靜脈 (VV)、動脈-靜脈 (AV)）、病患類型（新生兒、兒科、成人）、應用（呼吸、心臟、體外心肺復甦術 (ECPR)）。

受訪公司範例

  • Alung Technologies, Inc.
  • Eurosets SRL
  • Getinge AB（Getinge Group）
  • LivaNova PLC
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • Origen Biomedical, Inc.
  • Terumo Corporation
  • Xenios AG

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具，革新市場和競爭情報。

與查詢LLM或特定產業的SLM的典型做法不同，Global Industry Analysts建立了一個內容庫，其中收集了來自世界各地專家的資訊，包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師預測，企業的競爭地位將根據其總部所在國家、製造地以及進出口（成品和OEM）情況而改變。這種複雜多變的市場動態預計將從多個方面影響競爭對手，包括銷貨成本成本上升、盈利下降以及供應鏈重組等，以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 亞太其他地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP11898

Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market to Reach US$874.7 Million by 2030

The global market for Extracorporeal Membrane Oxygenation (ECMO) Machine estimated at US$643.8 Million in the year 2024, is expected to reach US$874.7 Million by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Neonates Patient, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$500.7 Million by the end of the analysis period. Growth in the Pediatric Patient segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$167.5 Million While China is Forecast to Grow at 8.0% CAGR

The Extracorporeal Membrane Oxygenation (ECMO) Machine market in the U.S. is estimated at US$167.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$197.4 Million by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market - Key Trends and Drivers Summarized

How Are Extracorporeal Membrane Oxygenation (ECMO) Machines Revolutionizing Critical Care?

Extracorporeal Membrane Oxygenation (ECMO) machines are transforming critical care by providing life-saving support to patients with severe respiratory or cardiac failure. ECMO is a form of extracorporeal life support (ECLS) that oxygenates a patient's blood outside the body, allowing the heart and lungs to rest and recover. ECMO machines work by drawing blood from the patient's body, removing carbon dioxide, adding oxygen, and then returning the oxygenated blood to the patient. This process offers an essential lifeline for individuals suffering from conditions such as acute respiratory distress syndrome (ARDS), cardiogenic shock, or complications from heart surgery, as well as those waiting for lung or heart transplants.

The rise of ECMO technology has revolutionized the management of patients with life-threatening respiratory and cardiac conditions, especially when conventional treatments, such as mechanical ventilation, fail to improve the patient's condition. ECMO machines are now widely used in neonatal, pediatric, and adult intensive care units (ICUs) as a last resort when other interventions are insufficient. The system’s ability to maintain oxygen delivery and blood circulation for extended periods provides critical time for the heart and lungs to heal, improving survival rates in patients with severe, life-threatening conditions. As advances in ECMO technology continue to evolve, the scope of its use in critical care is expanding, offering hope to patients who would otherwise face poor outcomes.

Why Are ECMO Machines Essential for Treating Severe Respiratory and Cardiac Failure?

ECMO machines are essential in treating patients with severe respiratory and cardiac failure because they provide temporary support to vital organs, allowing for recovery when other medical interventions have been exhausted. In cases of severe respiratory failure, such as ARDS or pneumonia, the lungs may be unable to adequately oxygenate the blood, leading to life-threatening complications. ECMO helps by bypassing the lungs entirely, oxygenating the blood outside the body and returning it to the circulatory system, ensuring that oxygen reaches vital organs while the lungs rest and heal. This is particularly important for patients whose lungs have been damaged by trauma, infection, or prolonged ventilation, where traditional mechanical ventilation may not be sufficient to maintain oxygen levels.

Similarly, ECMO is a critical tool for patients suffering from cardiac failure, such as those recovering from heart surgery, experiencing heart attacks, or in cardiogenic shock. In these cases, ECMO takes over the function of the heart by maintaining blood circulation and oxygen delivery. This allows the heart to recover from stress or damage while preventing complications such as organ failure, which can result from inadequate blood flow. ECMO also serves as a bridge to more permanent solutions like heart or lung transplants, giving critically ill patients the time needed for an organ to become available. With the increasing use of ECMO in emergency settings, such as for patients with severe COVID-19 complications, it has proven to be an invaluable tool in providing life support when other treatments are no longer effective, highlighting its importance in modern critical care.

What Are the Expanding Applications and Innovations in ECMO Technology?

The applications of ECMO technology are expanding rapidly, with innovations in the field pushing its use beyond traditional settings and enhancing its capabilities in treating critically ill patients. Initially used primarily in neonatal and pediatric ICUs, ECMO has become an increasingly common intervention in adult patients suffering from severe respiratory or cardiac failure. Its role in treating adult respiratory conditions gained particular attention during the COVID-19 pandemic, where ECMO was used to support patients with severe respiratory complications caused by the virus. As understanding of the technology grows, ECMO is being applied in a wider variety of clinical scenarios, including trauma patients with severe lung injury, post-cardiac arrest patients requiring resuscitation, and those experiencing complications from major surgeries.

Innovations in ECMO technology are enhancing its safety, efficiency, and accessibility. Recent advancements include the development of portable ECMO devices, which enable the transport of critically ill patients between hospitals or within large healthcare facilities. These portable systems allow patients to receive life-saving treatment while en route to specialized care centers, improving survival rates for patients in need of complex interventions. In addition, improvements in circuit design and materials, such as biocompatible coatings that reduce the risk of blood clotting and inflammation, have made ECMO therapy safer and more effective over longer periods. Advances in artificial lungs and oxygenators, which are central to ECMO’s functionality, are also increasing the efficiency of oxygen exchange, further improving outcomes for patients.

Furthermore, the integration of artificial intelligence (AI) and data analytics into ECMO systems is opening new possibilities for personalized care. AI algorithms can be used to monitor and adjust ECMO parameters in real time, optimizing the therapy for each patient based on their individual condition. This precision can reduce the risks associated with ECMO, such as bleeding or clotting, and improve the overall management of critically ill patients. As research and technology in the field of extracorporeal life support continue to advance, ECMO’s applications are expanding beyond ICUs, potentially becoming a staple in emergency care, trauma management, and even long-term chronic care for patients with heart and lung diseases.

What Factors Are Driving the Growth of the ECMO Market?

The growth of the Extracorporeal Membrane Oxygenation (ECMO) machine market is being driven by several key factors, including the rising incidence of respiratory and cardiac diseases, advancements in ECMO technology, and the increased use of ECMO in critical care settings. One of the primary drivers is the growing prevalence of conditions like ARDS, cardiogenic shock, and heart failure, all of which have high mortality rates and often require advanced life support. The COVID-19 pandemic also brought ECMO into the spotlight, as healthcare systems worldwide saw a surge in patients with severe respiratory failure who required ECMO support when other treatments, such as mechanical ventilation, were insufficient. The success of ECMO in improving survival rates for COVID-19 patients with acute lung failure has led to broader recognition of its value in managing respiratory crises, contributing to increased demand for ECMO machines in ICUs and emergency departments.

Technological advancements are also playing a significant role in the growth of the ECMO market. Innovations in device design, including the development of more compact and portable ECMO machines, have made it easier to transport patients while receiving ECMO support. This has expanded the use of ECMO beyond traditional hospital settings, enabling its application in field hospitals, ambulances, and other emergency care scenarios. In addition, improvements in oxygenator efficiency, pump technology, and biocompatible materials are reducing the risks associated with ECMO therapy, such as blood clotting and infection. These innovations are enhancing patient outcomes and increasing the adoption of ECMO in hospitals worldwide.

Another key factor driving the growth of the ECMO market is the rising awareness of the benefits of ECMO in treating critically ill patients, particularly in regions where the technology was previously underutilized. Increased training and education for healthcare professionals on how to operate ECMO machines and manage patients on ECMO support are leading to more widespread implementation of the technology. Furthermore, as healthcare systems in developing regions improve, there is a growing demand for advanced life support technologies like ECMO, which are seen as essential for managing complex cases of respiratory and cardiac failure. Additionally, favorable reimbursement policies and government support for critical care infrastructure are contributing to the market’s expansion, making ECMO more accessible to hospitals and clinics around the world.

In conclusion, the ECMO machine market is set for substantial growth, driven by the rising prevalence of severe respiratory and cardiac conditions, advancements in ECMO technology, and increased recognition of its life-saving capabilities. As ECMO continues to evolve, its applications in critical care, emergency response, and even long-term care will expand, offering new possibilities for improving patient outcomes in the most severe cases of organ failure. With ongoing innovation and increased investment in healthcare infrastructure, ECMO machines will remain a crucial component of modern critical care, providing hope and life-saving support for patients with life-threatening conditions.

SCOPE OF STUDY:

The report analyzes the Extracorporeal Membrane Oxygenation (ECMO) Machine market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Modality (Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV)); Patient Type (Neonates, Pediatric, Adult); Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (ECPR))

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Alung Technologies, Inc.
  • Eurosets S.R.L.
  • Getinge AB (Getinge Group)
  • LivaNova PLC
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • Origen Biomedical, Inc.
  • Terumo Corporation
  • Xenios AG

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Extracorporeal Membrane Oxygenation (ECMO) Machine - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Incidence of Cardiopulmonary Diseases and Respiratory Failures Driving ECMO Machine Demand
    • Growing Number of ECMO Centers Worldwide Expanding Access to Life-saving Treatment
    • Market Trends Toward Portable and Miniaturized ECMO Systems
    • Future Directions: Integration of AI and Machine Learning in ECMO Monitoring
    • Economic Factors Impacting the Affordability and Insurance Coverage for ECMO Therapy
    • Impact of Telemedicine on Remote ECMO Monitoring and Support
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Neonates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Neonates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Neonates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Pediatric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Adult by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Veno-Arterial (VA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Veno-Arterial (VA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Veno-Arterial (VA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Arterio-Venous (AV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Arterio-Venous (AV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Arterio-Venous (AV) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Veno-Venous (VV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Veno-Venous (VV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Veno-Venous (VV) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Respiratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Respiratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Respiratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Cardiac by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Cardiac by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Cardiac by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Extracorporeal Cardiopulmonary Resuscitation (ECPR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Extracorporeal Cardiopulmonary Resuscitation (ECPR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Extracorporeal Cardiopulmonary Resuscitation (ECPR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 28: World Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • JAPAN
    • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • CHINA
    • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • EUROPE
    • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • GERMANY
    • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • INDIA
    • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030
  • AFRICA
    • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates, Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates, Pediatric and Adult for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial (VA), Arterio-Venous (AV) and Veno-Venous (VV) for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR) for the Years 2015, 2025 & 2030

IV. COMPETITION